Month: April 2024

2065 posts
Quentin Véron is appointed Artistic Director of Morabito Paris

Quentin Véron is appointed Artistic Director of Morabito Paris

PARIS, April 3, 2024 /PRNewswire/ — House of Morabito Paris announces the arrival…
YS Biopharma Announces Full Repayment of US,000,000 Loan Facility

YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility

GAITHERSBURG, Md., April 3, 2024 /PRNewswire/ — YS Biopharma Co., Ltd. (Nasdaq:…
RevitaLash® Advanced Eyelash Conditioner Makes Triumphant Return to California after 10+ years

RevitaLash® Advanced Eyelash Conditioner Makes Triumphant Return to California after 10+ years

VENTURA, Calif., April 3, 2024 /PRNewswire/ — After more than a decade-long hiatus,…
BingX Lists Wormhole Protocol's Token to Expand Spot Offerings

BingX Lists Wormhole Protocol's Token to Expand Spot Offerings

VILNIUS, Lithuania, April 3, 2024 /PRNewswire/ — The leading global cryptocurrency exchange BingX…
Introducing MFinder: A Real-Time Lost Phone Tracking App

Introducing MFinder: A Real-Time Lost Phone Tracking App

NEW YORK, April 3, 2024 /PRNewswire/ — DataUniverse announced on the 3rd the…
Snail Games Unveils First Expansion Map and DLC for ARK: Survival Ascended

Snail Games Unveils First Expansion Map and DLC for ARK: Survival Ascended

CULVER CITY, Calif., April 3, 2024 /PRNewswire/ — Snail, Inc. (Nasdaq: SNAL)…
RSN Recognized Among Top 500 High-Growth Companies in Asia-Pacific by Financial Times

RSN Recognized Among Top 500 High-Growth Companies in Asia-Pacific by Financial Times

SEOUL, South Korea, April 3, 2024 /PRNewswire/ — RSN, a leading player…
Ractigen Announces First Patient Dosed in the Phase I Clinical Trial of RAG-01 for NMIBC

Ractigen Announces First Patient Dosed in the Phase I Clinical Trial of RAG-01 for NMIBC

JIANGSU, China, April 3, 2024 /PRNewswire/ — Ractigen Therapeutics, a pioneer in…